Pulp Friction

ProHub Comment

This case uses a straightforward market analysis approach to evaluate a new product launch decision. The candidate must calculate market sizing, conduct financial modeling across product lines, and assess whether the higher-margin antiviral segment justifies strategic pivot. The case emphasizes quantitative rigor combined with competitive positioning logic.

Estimated Time 17 minutes
Difficulty Easy
Source Wharton
10 / 100
Your client, TissueCo, is a large facial tissue manufacturer that sells to retailers. While the US facial tissue market suffered operational challenges due to Covid-19, the market is forecasted to recover and grow in 2021. While TissueCo has seen some improved numbers as they adapt to the pandemic, their profitability margin has fallen below their main competitors Kelly-Clark and Proxy and Gumbo. The CEO has invited you to help them out.

Clarifying Information

  1. The client is focused on US sales only
  2. TissueCo’s profitability margin dropped below its competitors before the COVID-19 outbreak but has further worsened after COVID-19
  3. TissueCo produces tissues that are standard, extra soft, and tissues with lotion
  4. There is no specific goal to improve profitability
  5. The expected CAGR in 2021 is 5.8%
Mock Interview
Interviewer

Your client, TissueCo, is a large facial tissue manufacturer that sells to retailers. While the US facial tissue market suffered operational challenges due to Covid-19, the market is forecasted to recover and grow in 2021. While TissueCo has seen some improved numbers as they adapt to the pandemic, their profitability margin has fallen below their main competitors Kelly-Clark and Proxy and Gumbo. The CEO has invited you to help them out.

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

TissueCo, a tissue manufacturer facing margin compression versus competitors, should launch anti-viral tissues to improve profitability, driven by pandemic-driven demand and a forecasted 20% profit margin versus 10-15% for existing products.

Key Insights:

  1. Market sizing requires segmentation by use case (illness duration, frequency, ancillary needs) rather than simple per-capita consumption
  2. Product-level profitability analysis reveals that new category can pull up overall company margins through favorable mix
  3. Higher willingness-to-pay from germ-conscious consumers justifies premium positioning despite smaller addressable market
  4. Supply chain risk and competitive response represent key execution risks requiring sensitivity analysis